AzTrials
AzTrials

Chronic PainNCT07351617

Turkish Version of the Pain Metacognitions Questionnaire

An observational study of Chronic Pain and Pain Metacognitions, run by Tokat Gaziosmanpasa University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Pain-related thoughts and beliefs play an important role in how individuals experience and cope with chronic pain. Metacognitions about pain, such as beliefs about the uncontrollability or harmfulness of pain-related thoughts, may influence emotional distress and pain-related outcomes. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Pain, Pain Metacognitions
How many people
210 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Feb 2026to 10 Jun 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of adults aged 18 years and older with chronic non-cancer pain.

Who may be able to join

  • Aged 18 years and older
  • Experiencing chronic non-cancer pain for at least three months
  • Ability to read and understand Turkish
  • Voluntary participation and provision of informed consent

Who cannot join

  • Presence of cancer-related pain
  • Severe cognitive impairment preventing completion of questionnaires
  • Incomplete or incorrectly completed questionnaires

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Müzeyyen Öz, PhD contact

+905368213404

fztmuzeyyenoz@gmail.com

Turkey (Türkiye)1 site
  • Çankırı Karatekin University

    Çankırı, 18000

    Müzeyyen Öz, PhD, +905368213404, fztmuzeyyenoz@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: Translation, Validity, and Reliability of the Turkish Version of the Pain Metacognitions Questionnaire

Pain-related thoughts and beliefs play an important role in how individuals experience and cope with chronic pain. Metacognitions about pain, such as beliefs about the uncontrollability or harmfulness of pain-related thoughts, may influence emotional distress and pain-related outcomes. The Pain Metacognitions Questionnaire was developed to assess these beliefs; however, a validated Turkish version is not currently available. The aim of this study is to translate the Pain Metacognitions Questionnaire into Turkish and to evaluate its validity and reliability in adults with chronic non-cancer pain. This observational study will include adult individuals experiencing chronic pain for at least three months. Data will be collected using self-report questionnaires administered in a single assessment session. The findings of this study are expected to provide a reliable and valid measurement tool for assessing pain-related metacognitions in Turkish-speaking populations and to support future clinical and research applications in chronic pain management.

Read the detailed description

Chronic pain is a complex condition influenced not only by biological factors but also by cognitive and emotional processes. Metacognitions, defined as beliefs about one's own thoughts, have been shown to play a significant role in the persistence and management of chronic pain. The Pain Metacognitions Questionnaire was developed to assess pain-related metacognitive beliefs, including perceptions about the uncontrollability, danger, and usefulness of pain-related thoughts. Despite its growing use in research, a validated Turkish version of this questionnaire is currently lacking.

This study is designed as an observational, cross-sectional investigation aiming to translate the Pain Metacognitions Questionnaire into Turkish and to examine its psychometric properties in adults with chronic non-cancer pain. The translation process will follow standard forward-backward translation procedures to ensure linguistic and conceptual equivalence. Content validity will be evaluated by expert review.

Participants will be adults aged 18 years and older who have experienced chronic non-cancer pain for at least three months. After providing informed consent, participants will complete the Turkish version of the Pain Metacognitions Questionnaire along with additional validated self-report measures assessing pain-related and psychological constructs. Data collection will be conducted through face-to-face or online survey methods, and all assessments will be completed at a single time point.

Psychometric analyses will include evaluation of internal consistency, test-retest reliability, construct validity, and factor structure. Correlational analyses will be used to examine relationships between pain metacognitions and related psychological variables. The results of this study are expected to contribute to the assessment of cognitive processes in chronic pain and to provide a valid and reliable instrument for use in Turkish clinical and research settings.

Being tested
No Intervention (Observational Study)
Keywords
chronic pain, pain metacognitions, questionnaire validation, reliability
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No Intervention (Observational Study)Other

    This is an observational study. No intervention is administered. Data are collected using self-report questionnaires only.

Study groups in NCT07351617
Study groupRoleWhat they receive
Adults with Chronic PainAdults aged 18 years and older with chronic non-cancer pain who participate voluntarily in this observational study.
Receives: Other: No Intervention (Observational Study)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Metacognitions Score

    Pain metacognitions will be assessed using the Turkish version of the Pain Metacognitions Questionnaire. The questionnaire evaluates metacognitive beliefs related to pain, including beliefs about the uncontrollability, danger, and usefulness of pain-related thoughts. Higher scores indicate more maladaptive pain-related metacognitions.

    Measured: At enrollment (single assessment)

Secondary outcomes (4)
  1. Pain Intensity

    Pain intensity will be measured using a numerical rating scale as part of the Brief Pain Inventory, where higher scores indicate greater pain intensity.

    Measured: At enrollment (single assessment)

  2. Pain Interference

    Pain interference will be assessed using the Brief Pain Inventory, evaluating the extent to which pain interferes with daily activities and functioning. Higher scores indicate greater pain-related interference.

    Measured: At enrollment (single assessment)

  3. Pain Catastrophizing

    Pain catastrophizing will be measured using a validated self-report questionnaire assessing rumination, magnification, and helplessness related to pain. Higher scores indicate greater levels of pain catastrophizing.

    Measured: At enrollment (single assessment)

  4. Anxiety and Depression Symptoms

    Symptoms of anxiety and depression will be evaluated using a validated self-report scale. Higher scores indicate greater psychological distress.

    Measured: At enrollment (single assessment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2026
  2. Study start1 Feb 2026 (estimated)
  3. Primary completion19 May 2026 (estimated)
  4. Study completion10 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
210 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07351617
Sponsor's protocol ID
CKU-PMQ-TR-2025
Status last verified
Jan 2026
First submitted
10 Jan 2026
Last updated
20 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to privacy and confidentiality considerations.

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Pain and Pain Metacognitions, run by Tokat Gaziosmanpasa University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Müzeyyen Öz, PhD (+905368213404, fztmuzeyyenoz@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Metacognitions Score (time frame: At enrollment (single assessment)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in